Targeting HIF function: The debate continues

Blood

Volumn 124, Issue 24, 2014, Pages 3510-3511

  Vyas, Paresh ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALLELE; CELL HYPOXIA; HEMATOLOGIC MALIGNANCY; HUMAN; NONHUMAN; NOTE; PROTEIN TARGETING; TUMOR SUPPRESSOR GENE; ANIMAL; EXPERIMENTAL NEOPLASM; HEMATOPOIETIC STEM CELL; METABOLISM;

ANIMALS; GENES, TUMOR SUPPRESSOR; HEMATOPOIETIC STEM CELLS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LEUKEMIA, MYELOID, ACUTE; NEOPLASMS, EXPERIMENTAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84916200633     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-10-605055     Document Type: Note

References (10)

1. Velasco-Hernandez T, Hyrenius-Wittsten A, Rehn M, Bryder D, Cammenga J. HIF-1a can act as a tumor suppressor gene in murine acute myeloid leukemia. Blood. 2014;124(24):3597-3607.
2. Suda T, Takubo K, Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell. 2011;9(4):298-310.
3. Kusumbe AP, Ramasamy SK, Adams RH. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature. 2014;507(7492):323-328.
4. Arai F, Hirao A, Ohmura M, et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2004;118(2):149-161.
5. Ishikawa F, Yoshida S, Saito Y, et al. Chemotherapyresistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol. 2007;25(11):1315-1321.
6. Takubo K, Goda N, Yamada W, et al. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell. 2010;7(3):391-402.
7. Guitart AV, Subramani C, Armesilla-Diaz A, et al. Hif-2a is not essential for cell-autonomous hematopoietic stem cell maintenance. Blood. 2013;122(10):1741-1745.
8. Wang Y, Liu Y, Malek SN, Zheng P, Liu Y. Targeting HIF1α eliminates cancer stem cells in hematological malignancies. Cell Stem Cell. 2011;8(4):399-411.
9. Zhang H, Li H, Xi HS, Li S. HIF1 a is required for survival maintenance of chronic myeloid leukemia stem cells. Blood. 2012;119(11):2595-2607.
10. Rouault-Pierre K, Lopez-Onieva L, Foster K, et al. HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress. Cell Stem Cell. 2013;13(5):549-563.